Period-tracking app Flo closed a $50 million Series B financing round, bringing the company’s valuation to $800 million. 

The round was led by VNV Global and Target Global. London-based Flo said the latest round brings its total raise to $65 million.

Flo said it will use the capital to improve personalization and give users more advanced insights into their cycles and symptoms. The company also plans to hire employees across product, engineering, research and development, data science, and medical roles.

“Too often, people encounter misinformation when searching on the Internet for signs and symptoms of conditions, especially when it comes to taboo topics such as menstrual and sexual health,” Cath Everett, Flo’s VP of product, said in a statement.

“Our users often come to Flo for period or ovulation tracking, and stay for the wealth of science-backed content, expert-led courses and accurate cycle predictions. We’re fortunate to partner with the top universities and conduct cutting-edge medical research. With this funding, we’ll be able to further democratize access to credible health information, helping people better understand their unique signs and symptoms on an even larger scale.”

In January, Flo settled with the Federal Trade Commission over a complaint alleging the tracking app shared user data with marketing and analytics services at Facebook and Google. 

The company landed a $12 million Series A extension in 2018 and a $5 million Series A in 2017. 

Copenhagen-based Corti.ai, maker of artificial intelligence products to improve workflow and quality during patient consults, raised $27 million in Series A funding.

The round was led by Vaekstfonden, the Danish state investment fund, and Chr. Augustinus Fabrik with participation from existing investors Hearcore, Id Invest and byFounders.

Corti.ai plans to use the financing to push into the U.S. primary care market.

“We are very proud of our work in the field of emergency medicine, but already today we are analyzing roughly 250,000 low acuity consultations per month, proving that the technology can be a massive value-add for ... telehealth companies, clinical call-centers and GPs around the world,” cofounder and CTO Lars Maaløe said in a statement.

The funding builds upon a $5 million seed round from 2019. In 2018, the company partnered with the European Emergency Number Association to use its technology as a digital assistant for medical dispatchers. 

Pediatric teletherapy provider DotCom Therapy announced it had raised $13 million in Series A funding.

The round was led by New Capital Partners with participation from LRVHealth and OSF Ventures.

DotCom said it will use the funding to add new features to its proprietary tech, Zesh, grow its customer base among schools, and expand partnerships with healthcare providers and payers. 

“This funding will fuel our expansion across healthcare systems, where the widespread therapist shortage is overburdening staff, greatly impacting the patients and families they serve,” founder and president Rachel Mack Robinson said in a statement. 

“Through the work we’re doing with OSF Healthcare, the direct access LRVHealth can provide through its network of strategic health system partners, and New Capital Partners’ experience building healthcare and telehealth companies, we believe we have the right team in place to grow our partnerships with health systems and payers by ensuring we’re delivering the technology and support to reach more kids in need.”